SCHEMBL8626702

SCHEMBL8626702

CC[C](C1CC1)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27992189 0.90 NOS2 (0.35)
SCHEMBL6989750 0.90 NOS2 (0.35)
SCHEMBL5720720 0.87 CES2 (0.41)
SCHEMBL7392020 0.87 CES2 (0.41)
SCHEMBL6990609 0.87 CES2 (0.41)
SCHEMBL27603553 0.76 ALDH1A1 (0.35)
SCHEMBL8324332 0.75 TSHR (0.38)
SCHEMBL7105986 0.71 CNR2 (0.34)
SCHEMBL5420436 0.69
SCHEMBL126584 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5795905-A 3-AMINO-5-PHENYL-1,2,4-TRIAZOLES NEUROCRINE BIOSCIENCES, INC. (US) 1998-08-18 US disclosed
EP-0846108-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1998-06-10 EP disclosed
EP-0427827-B1 8-alpha-ACYLAMINO-ERGOLINES, THEIR PREPARATION AND USE AS DRUGS SCHERING AG (DE) 1997-01-15 EP disclosed
WO-1996039400-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1996-12-12 WO disclosed